Clinical Case Study: Clinical Use of the Looming Vulnerability Construct for Performance Anxiety in a Dance Recital
- Mirtazapine reduces social anxiety and improves quality of life in women with social phobia. Mortberg, Ewa // Evidence Based Mental Health;Aug2006, Vol. 9 Issue 3, p75
The article comments on the study by M. Muehlbacher and colleagues on the effectiveness of mirtazapine in reducing social anxiety and improving quality of life in women with social phobia. The results of placebo controlled study of mirtazapine show rapid and credible effects and is relatively...
- Psychometric properties of social phobia inventory among Iranian students. Amouzadeh, Mahdi Hassanvand; Benam, Keyvan Fardaei // Journal of Research & Health;Summer2015, Vol. 5 Issue 2, p149
Developing a simple and effective tool is necessary in epidemiological studies and clinical screening to assess the individuals suffering from social phobia. This study was conducted for validity and reliabity of social phobia inventory (SPIN) in Iranian students. The 581 uneversity students...
- Anxiety and social phobia disorder. Roller, Louis; Gowan, Jenny // Australian Journal of Pharmacy;Feb2013, Vol. 94 Issue 1113, p54
The article presents information on the types, non-pharmacological treatments of anxiety and pharmacological treatments of social anxiety. It mentions that anxiety is as mood state which is characterized by tension in which an individual anticipates catastrophe, danger and misfortune. The types...
- Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Menezes, Gabriela; Coutinho, Evandro; Fontenelle, Leonardo; Vigne, Paula; Figueira, Ivan; Versiani, Márcio // Psychopharmacology;May2011, Vol. 215 Issue 1, p1
Rationale: A growing number of controlled clinical trials suggest that different second-generation antidepressants (SGA) may be effective in the treatment of social anxiety disorder (SAD). Objectives: The aim of the present study is to evaluate the effectiveness of SGA in SAD and to investigate...
- Overcoming debilitating shyness with Nardil. R.M.D. // Cortlandt Forum;7/25/96, Vol. 9 Issue 7, p138
Provides information on the treatment of patients with pathologic shyness correlated with an anxiety disorder known as generalized social phobia. Limited use of monoamine oxidase as Nardil; Positive response of neurotic patients to phenelzine.
- Managing social anxiety: a cognitive behavioral therapy approach. Doherty, Kieran // Healthcare Counselling & Psychotherapy Journal;Jul2011, Vol. 11 Issue 3, p40
The article reviews the second editions of the books "Managing Social Anxiety: A Cognitive Behavioral Therapy Approach: Therapist Guide," and "Managing Social Anxiety: A Cognitive Behavioral Therapy Approach: Workbook," by Debra A. Hope, Richard G. Heimberg and Cynthia L. Turk.
- Social anxiety. // Mayo Clinic Health Letter;May2011, Vol. 29 Issue 5, p6
The article discusses the symptoms of social anxiety, and the treatments and means available to overcome it. This is defined as the inability to deal with others on a social basis out of fear of humiliation or maladroitness, causing stomach upsets, sweating or diarrhea. To address this problem,...
- Prompt diagnosis of social anxiety disorder leads to effective treatment. // Healthcare Counselling & Psychotherapy Journal;Oct2013, Vol. 13 Issue 4, p4
The article reports on guidelines on the treatment of social anxiety disorder which were released in 2013 by Great Britain's National Institute for Health and Clinical Excellence. The guidelines, which discuss the prevalence of social anxiety disorder and barriers to social anxiety disorder...
- NICE issues guideline to help people with social anxiety disorder. // Mental Health Practice;Jun2013, Vol. 16 Issue 9, p4
The article reports that National Institute for Health and Care Excellence (NICE) has designed the guidance which helps the healthcare professionals in recognizing social anxiety disorder and also provides effective treatments to the patients.